[{"data":1,"prerenderedAt":335},["ShallowReactive",2],{"slug-where-does-blood-testing-stand-today":3},{"post":4,"relatedPosts":197,"relatedBooks":334},{"id":5,"date":6,"date_gmt":7,"guid":8,"modified":10,"modified_gmt":11,"slug":12,"status":13,"type":14,"link":15,"title":16,"content":18,"excerpt":21,"author":23,"featured_media":24,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":29,"categories":30,"tags":34,"project_category":48,"contact_email_category":49,"yst_prominent_words":50,"class_list":71,"better_featured_image":94,"acf":132,"yoast_meta":141,"_links":144},22248,"2018-11-03T13:51:54","2018-11-03T11:51:54",{"rendered":9},"https:\u002F\u002Fmedicalfuturist.com\u002F","2022-05-27T09:52:37","2022-05-27T07:52:37","where-does-blood-testing-stand-today","publish","post","https:\u002F\u002Fmedicalfuturist.com\u002Fwhere-does-blood-testing-stand-today",{"rendered":17},"Where Does Blood Testing Stand Today?",{"rendered":19,"protected":20},"\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"5px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp style=\"color: #555;font-size: 12px;line-height: 14px\">THIS ARTICLE HAS NOT BEEN UPDATED SINCE 2018. THE INFORMATION SHARED IN THE ARTICLE WAS ACCURATE AT THE TIME OF ITS PUBLICATION, BUT IT MAY BE OUT OF DATE NOW. \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fmagazine\">BROWSE OUR LATEST ARTICLES HERE\u003C\u002Fa>\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\u003C\u002Ftbody>\u003C\u002Ftable>\n\n\n\n\u003Cp>The dream about a drop of blood signaling a wide range of diagnostic results was shattered with Elizabeth Holmes and the Theranos scam. The machination of the company has set back the innovation of blood testing and investment into the field for years. However, there’s always hope. The Medical Futurist looked around where blood testing stands today and what’s the future it is heading towards.\u003C\u002Fp>\n\n\n\n\u003C!--more-->\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Dreaming about a home laboratory\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Stephen just came home from walking his dog, Barney, an always smiling labrador. The 40-something took off his smart shoes, sat back on the yellow couch that he and her partner, Sara, were fighting about at IKEA (of course, she won the argument) and started reading the report that the sensors in the sole sent him about the walk. The flashy document appeared in a see-through virtual panel above the mahogany coffee table. Suddenly, another notification arrived with flashy red dots. Stephen seemed to be annoyed by the message that said he should have the regular blood test soon.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\">\u003Cdiv class=\"wp-block-embed__wrapper\">\n\u003Ciframe loading=\"lazy\" title=\"The Theranos Scam And The State Of Blood Testing - The Medical Futurist\" width=\"640\" height=\"360\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002F_N-gKgNXDMY?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen>\u003C\u002Fiframe>\n\u003C\u002Fdiv>\u003C\u002Ffigure>\n\n\n\n\u003Cp>However, after contemplating about his experiences as a child with standing in line for a lab test in a crowded hospital, nurses drawing many ampoules of blood and him waiting several days for the results, he smiled and thought to himself – he should be glad things have changed. Afterward, Stephen took out his \u003Cstrong>home lab testing kit, which only required one drop of blood and tested everything from his white blood cell count to his glucose level. The results were taken to the cloud, analyzed, and within a couple of minutes – his see-through virtual panel showed every insight about his blood\u003C\u002Fstrong>. Suddenly, his phone started ringing, and he thought that it must be his doctor about one of the results out of the normal range – and his throat began to be tight with fear.\u003C\u002Fp>\n\n\n\n\u003Cp>He picked up the phone, but something was still ringing. Stephen noticed then that it was actually a smart sleep alarm and only a dream. He got disappointed as he had to go to the hospital for some laboratory tests that day.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image alignnone wp-image-22250 size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"580\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FBlood-Glucose-Monitoring.jpg\" alt=\"blood testing at home\" class=\"wp-image-22250\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FBlood-Glucose-Monitoring.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FBlood-Glucose-Monitoring-768x512.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FBlood-Glucose-Monitoring-512x341.jpg 512w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fdirectorsblog.nih.gov\u002F\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>What’s so devastating about the Theranos scam?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>The dream about home laboratories and the revolution of blood testing within reach was not shattered by a smart sleep alarm, rather an ill-famed enterprise, Theranos.\u003C\u002Fp>\n\n\n\n\u003Cp>In 2014, the company made headlines by raising more than 700 million dollars of capital – today its online space only signifies the start of the insolvency proceeding. Three years ago, Theranos \u003Ca href=\"https:\u002F\u002Fwww.businessinsider.com\u002Fthe-history-of-silicon-valley-unicorn-theranos-and-ceo-elizabeth-holmes-2018-5\">was evaluated at 9 billion dollars\u003C\u002Fa> and its founder and CEO, Elizabeth Holmes, was on the cover of \u003Ca href=\"https:\u002F\u002Fwww.vanityfair.com\u002Fnews\u002F2018\u002F06\u002Felizabeth-holmes-is-trying-to-start-a-new-company\">The New York Times Style Magazine, Forbes, Fortune, or Inc\u003C\u002Fa>., and made to the \u003Ca href=\"https:\u002F\u002Fwww.businessinsider.com\u002Fthe-silicon-valley-100-2015-1-100-2015-6\">lists of top executives\u003C\u002Fa>. Today, the press mainly reports about her pathological lying tendencies and \u003Ca href=\"https:\u002F\u002Fwww.theguardian.com\u002Fcommentisfree\u002F2018\u002Fjun\u002F03\u002Ftheranos-elizabeth-holmes-media-emperors-new-startup\">how the FDA pulled the plug on Theranos\u003C\u002Fa>. The Security and Exchange Commission (SEC) \u003Ca href=\"https:\u002F\u002Fwww.theguardian.com\u002Ftechnology\u002F2018\u002Fmar\u002F14\u002Ftheranos-founder-elizabeth-holmes-fraud-charge\">charged Holmes with “massive fraud”\u003C\u002Fa>, she was fined $500,000, lost voting control of Theranos and was banned from being an officer or director of any public company for 10 years.\u003C\u002Fp>\n\n\n\n\u003Cp>However, the marks of Theranos are still palpable in the industry – and that’s the most devastating about the shenanigans of the company. \u003Cstrong>Investors are more cautious when it comes to supporting start-ups with ideas for bringing forward \u003C\u002Fstrong>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fwww.grandviewresearch.com\u002Findustry-analysis\u002Fblood-testing-market\">the $51 billion market\u003C\u002Fa>\u003C\u002Fstrong>\u003Cstrong> dominated by a few large companies and aiming to disrupt the blood testing procedure. Any enterprise that says it can do a blood test for less than $50 – Theranos promised $2.90 – or will be able to carry out dozens of tests on a tiny sample – Holmes said they will perform hundreds of tests on one drop of blood – will become instantly suspicious, has to explain how it is different from the ill-famed company and has to deliver rock-solid evidence, \u003C\u002Fstrong>although the latter is actually a great consequence as human lives are at stake here.\u003C\u002Fp>\n\n\n\n\u003Cp>In spite of the hindering factors, numerous companies are working towards the dream of testing blood at home, having the results within a minimum of time or performing dozens of tests on such a small amount of the red fluid as possible.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image alignnone wp-image-14666 size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"445\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Ftheranos-elizabeth-holmes.jpg\" alt=\"Theranos - Elizabeth Holmes\" class=\"wp-image-14666\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Ftheranos-elizabeth-holmes.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Ftheranos-elizabeth-holmes-768x393.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Ftheranos-elizabeth-holmes-512x262.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Ftheranos-elizabeth-holmes-458x234.jpg 458w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003Cfigcaption>Source: www.wsj.com\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Silicon Valley companies breaking out of the shadow of Theranos\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Luckily, the Theranos scam did not wholly destroy the entrepreneurial spirit of the blood testing market. However, the majority of the companies have to define themselves against Theranos – how they are different from this disastrous undertaking.\u003C\u002Fp>\n\n\n\n\u003Cp>A San Diego based company, \u003Ca href=\"https:\u002F\u002Fwww.genalyte.com\">Genalyte\u003C\u002Fa> can run up to 128 different tests on a single finger prick of blood in under 15 minutes. As the decade-old company’s profile is too similar to Theranos, \u003Ca href=\"https:\u002F\u002Fwww.genalyte.com\u002Fhow-blood-testing-startups-are-pitching-themselves-after-the-theranos-scandal\u002F\">the management tries to differentiate it\u003C\u002Fa> by emphasizing the clinical trials it is conducting — two have been completed so far — and openly sharing information about how its technology works.\u003C\u002Fp>\n\n\n\n\u003Cp>Another Silicon Valley startup, \u003Ca href=\"https:\u002F\u002Fathelas.com\u002F\">Athelas\u003C\u002Fa>, developed a portable diagnostic device leveraging deep learning and machine vision to rapidly measure white blood cell count and to tell the medical professional whether it can identify leukemia, infections, inflammations and other diseases. In an \u003Ca href=\"https:\u002F\u002Fwww.marketwatch.com\u002Fstory\u002Fhow-blood-testing-startups-are-pitching-themselves-after-theranos-scandal-2018-06-22\">article\u003C\u002Fa>, the company’s founder Tanay Tandon said that contrary to Theranos, Athelas has a data-oriented approach and it’s working with regulatory agencies, including to design its trials.\u003C\u002Fp>\n\n\n\n\u003Cp>The Boston and Neuchatel, Switzerland-based company, \u003Ca href=\"https:\u002F\u002Fwww.1dropdx.com\u002F\">1Drop Diagnostics\u003C\u002Fa>, has a diagnostic panel housed on a biochip that is able to deliver a test result within 15 minutes from a single drop of blood. As \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fcontent\u002F1drop-diagnostics-draws-425m-portable-blood-diagnostic-panel\">MobiHealthNews found\u003C\u002Fa>, others like Seventh Sense Biosystems, \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fcontent\u002Feverlywell-picks-2-million-expand-home-testing-kit-platform\">Everlywell\u003C\u002Fa> and \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fcontent\u002Fmylab-box-expands-home-testing-kit-6-new-std-tests\">myLabBox\u003C\u002Fa> are also looking to reinvent home blood draws and testing.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image alignnone wp-image-22251 size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"370\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FAthelas_Blood-testing.png\" alt=\"Athelas\" class=\"wp-image-22251\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FAthelas_Blood-testing.png 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FAthelas_Blood-testing-768x326.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FAthelas_Blood-testing-512x218.png 512w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003Cfigcaption>Source: https:\u002F\u002Fblog.athelas.com\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Innovative blood testing goes global\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>The Finnish company, \u003Ca href=\"https:\u002F\u002Fnightingalehealth.com\u002F\">Nightingale\u003C\u002Fa> – after the founder of nursing, Florence Nightingale – aims to solve the burden of chronic disease through predictive health and early diagnosis – based on its blood test. The company provides over 220 biomarkers from one single blood sample – and \u003Ca href=\"https:\u002F\u002Fwww.forbes.com\u002Fsites\u002Fgemmamilne\u002F2018\u002F10\u002F22\u002Ffinnish-blood-testing-startup-is-going-beyond-the-theranos-dream\u002F#10538c3520a4\">with the help of amino acids, for example, they are able to predict the prevalence of type 2 diabetes 10 years before the condition shows\u003C\u002Fa>. Utterly different from Theranos, Nightingale is keen on making their research public: \u003Ca href=\"https:\u002F\u002Fnightingalehealth.com\u002Fpublications\">they’ve been published in over 150 publications\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Cp>Singapore-based Lucence Diagnostics uses blood sampling for late-stage lung cancer. Compared to the standard tissue biopsy, the blood sample test is less invasive, less painful, and yields results within a day instead of ten. Moreover, these tests could help the doctor choose the appropriate medication for patients. Since its establishment in 2016, Lucence Diagnostics has also been able to apply this testing approach to late-stage colon and pancreatic cancer, but they screen for nasopharyngeal and breast cancer too.\u003C\u002Fp>\n\n\n\n\u003Cp>An Israeli company, \u003Ca href=\"https:\u002F\u002Fwww.pixcell-medical.com\u002F\">PixCell Medical Technologies\u003C\u002Fa>, developed a portable diagnostic device, more specifically a hematology analyzer, which performs a complete blood count (CBC) wherever the patient is. From one finger prick, they analyze 20 standard CBC parameters within 5 minutes, including red blood cell count, hemoglobin and platelet parameters.\u003C\u002Fp>\n\n\n\n\u003Cp>Wife and husband team Sarita and Anand Kumble set up the New Zealand-based biomedical company, \u003Ca href=\"https:\u002F\u002Fwww.pictordx.com\u002Fmedia\">Pictor\u003C\u002Fa> in 2006 after returning to New Zealand from the US and India. They aimed to create an affordable testing kit for infectious diseases in emerging countries. The blood testing kit’s \u003Ca href=\"https:\u002F\u002Fwww.nbr.co.nz\u002Farticle\u002Fnz-diagnostic-company-pictor-scores-major-licensing-deal-low-cost-blood-test-b#.V4gnKCd7Sfg.email\">modular design took more than three years to perfect\u003C\u002Fa> and allows up to eight simultaneous tests, with just one drop of blood on a microscopic slide.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image alignnone wp-image-22252\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"310\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FInnovative-Blood-Testing.jpg\" alt=\"blood testing\" class=\"wp-image-22252\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FInnovative-Blood-Testing.jpg 600w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FInnovative-Blood-Testing-512x265.jpg 512w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \u002F>\u003Cfigcaption>Source: www.nature.com\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Research promises more to come\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Scientists at Columbia University designed a platform called \u003Ca href=\"https:\u002F\u002Fmbio.asm.org\u002Fcontent\u002F9\u002F5\u002Fe02007-18\">BacCapSeq\u003C\u002Fa>, a new form of identifying bacteria that could help patients avoid sepsis. The first-of-its-kind test can simultaneously screen for all known human pathogenic bacteria – while identifying the genes that give rise to antibiotic resistance. \u003Ca href=\"https:\u002F\u002Fwww.sciencealert.com\u002Fpowerful-new-diagnostic-tool-screen-all-known-bacterial-infections-simultaneously-sepsis-baccapseq-antimicrobial-resistance\">The researchers say the method has the potential to significantly accelerate the diagnosis of lethal bacterial infections\u003C\u002Fa>, ultimately helping to save thousands of lives annually. Currently, the team is working on another platform – that could do the same for fungal infections.\u003C\u002Fp>\n\n\n\n\u003Cp>However, diagnostics based on blood tests are not only useful for prevention. Another ground-breaking research could spare unnecessary chemotherapy – and its side effects – for cancer patients. A new blood test that’s in clinical trials at more than 40 hospitals in Australia and New Zealand could determine whether cancer patients after surgery need chemotherapy or not. Results from the same test could also help to scale the dose for the patients who do need chemotherapy, depending on their risk of cancer returning.\u003C\u002Fp>\n\n\n\n\u003Cp>Moreover, blood samples could help the police, too. Manfred Kayser at Erasmus University Medical Centre in the Netherlands is currently developing new \u003Ca href=\"http:\u002F\u002Fwww.bbc.co.uk\u002Fnews\u002Fscience-environment-19566022\">DNA tests that might enable a person’s age, physical appearance, and geographic origin\u003C\u002Fa>, to be predicted from a blood sample, which could help police identify criminal suspects or badly decomposed bodies.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image alignnone size-full wp-image-22253\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"489\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FFrontiers-of-Blood-Testing.jpg\" alt=\"blood testing\" class=\"wp-image-22253\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FFrontiers-of-Blood-Testing.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FFrontiers-of-Blood-Testing-370x208.jpg 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FFrontiers-of-Blood-Testing-768x432.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002FFrontiers-of-Blood-Testing-512x288.jpg 512w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003Cfigcaption>Source: www.firstpost.com\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>What about the future?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Bill Gates, co-founder of Microsoft \u003Ca href=\"https:\u002F\u002Fwww.wired.com\u002Fstory\u002Fwired25-bill-gates-stephen-quake-blood-tests\u002F\">believes that the future of healthcare\u003C\u002Fa> is about noninvasive blood tests. \u003Cstrong>“More accurate, less expensive, and earlier diagnosis of issues will revolutionize how we treat people and prevent disease while reducing costs,” explained Gates.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>I agree with this prediction, moreover, I add that point-of-care, as well as home lab testing, will be the most significant advancement in the field – completely changing the methods used in primary care and diagnostics. Coupled with portable mobile technology, it could enable doctors in rural or developing regions to give an accurate diagnosis without the need to travel or wait for the results for days. Thus, while Theranos caused a setback in the development path of blood testing, it at least showed that the field is in dire need of innovation and that the revolution of blood testing will not be a quick process. Somewhere in the next decades, due to the hard work of scientists and biotech companies, we might have the home laboratory of our dreams.\u003C\u002Fp>\n\n\n\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"10px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp>\u003Cstrong>At The Medical Futurist, we are building a community for making a bold vision about the future of healthcare reality today.\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Ciframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FFIbMejImnxs\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\">\u003C\u002Fiframe>\n\u003Cp>If you’d like to support this mission, we invite you to \u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">join The Medical Futurist Patreon Community\u003C\u002Fa>. A community of empowered patients, future-oriented healthcare professionals, concerned health policymakers, sensible health tech developers, and enthusiastic medical students. If there were ever a time to join us, it is now. Every contribution, however big or small, powers our research and sustains our future.\u003C\u002Fp>\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">\u003Cstrong style=\"background-color: #e71d3299; color: #000;\">Click here to support The Medical Futurist from as little as $3\u003C\u002Fstrong>\u003C\u002Fa> – it only takes a minute. Thank you.\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\n\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\u003Cp> \u003C\u002Fp>\n",false,{"rendered":22,"protected":20},"\u003Cp>The dream about a drop of blood signaling a wide range of diagnostic results was shattered with Elizabeth Holmes and the Theranos scam. The machination of the company has set back the innovation of blood testing and investment into the field for years. However, there’s always hope. The Medical Futurist looked around where blood testing stands today and what’s the future it is heading towards\u003C\u002Fp>\n",6,22249,"closed",true,"","standard",{"_acf_changed":20,"footnotes":27},[31,32,33],500,521,497,[35,36,37,38,39,40,41,42,43,44,45,46,47],550,207,555,246,669,277,849,289,1118,297,425,427,159,[],[],[51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70],2883,2905,2885,2907,2887,2909,2889,2891,1883,2893,2765,2895,2875,2897,2877,2899,2879,2901,2881,2903,[72,14,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93],"post-22248","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-future-medicine","category-portable-diagnostics","tag-theranos","tag-digital-health","tag-blood-draw","tag-future","tag-blood","tag-home","tag-health-market","tag-innovation","tag-blood-testing","tag-laboratory","tag-technology-2","tag-testing","tag-blood-test",{"id":24,"alt_text":95,"caption":27,"description":27,"media_type":96,"media_details":97,"post":5,"source_url":131},"blood testing","image",{"width":98,"height":99,"file":100,"sizes":101,"image_meta":128},1921,1081,"2018\u002F11\u002F045_bloodtesting.gif",{"medium":102,"large":108,"thumbnail":113,"medium_large":117,"1536x1536":118,"large_old_512x288":123},{"file":103,"width":104,"height":105,"mime-type":106,"source_url":107},"045_bloodtesting-370x208.gif",370,208,"image\u002Fgif","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F045_bloodtesting-370x208.gif",{"file":109,"width":110,"height":111,"mime-type":106,"source_url":112},"045_bloodtesting-768x432.gif",768,432,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F045_bloodtesting-768x432.gif",{"file":114,"width":115,"height":115,"mime-type":106,"source_url":116},"045_bloodtesting-150x150.gif",150,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F045_bloodtesting-150x150.gif",{"file":109,"width":110,"height":111,"mime-type":106,"source_url":112},{"file":119,"width":120,"height":121,"mime-type":106,"source_url":122},"045_bloodtesting-1536x864.gif",1536,864,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F045_bloodtesting-1536x864.gif",{"file":124,"width":125,"height":126,"mime-type":106,"source_url":127},"045_bloodtesting-512x288.gif",512,288,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F045_bloodtesting-512x288.gif",{"aperture":129,"credit":27,"camera":27,"caption":27,"created_timestamp":129,"copyright":27,"focal_length":129,"iso":129,"shutter_speed":129,"title":27,"orientation":129,"keywords":130},"0",[],"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F11\u002F045_bloodtesting.gif",{"related_posts":133,"related_posts_footer":137,"cta_type":27,"cta_color":27,"subtitle":27,"related_books":20},[134,135,136],13949,15447,15644,[138,139,140],21053,21733,14660,{"yoast_wpseo_title":142,"yoast_wpseo_metadesc":143,"yoast_wpseo_canonical":15},"Blood Testing: The Theranos Scam And The State Of Blood Tests","Blood testing: The Medical Futurist looked around where blood testing technology stands today & what’s the future blood tests are heading towards",{"self":145,"collection":151,"about":154,"author":157,"replies":160,"version-history":163,"predecessor-version":167,"wp:featuredmedia":171,"wp:attachment":174,"wp:term":177,"curies":193},[146],{"href":147,"targetHints":148},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F22248",{"allow":149},[150],"GET",[152],{"href":153},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts",[155],{"href":156},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fpost",[158],{"embeddable":26,"href":159},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F6",[161],{"embeddable":26,"href":162},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=22248",[164],{"count":165,"href":166},12,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F22248\u002Frevisions",[168],{"id":169,"href":170},46510,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F22248\u002Frevisions\u002F46510",[172],{"embeddable":26,"href":173},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F22249",[175],{"href":176},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=22248",[178,181,184,187,190],{"taxonomy":179,"embeddable":26,"href":180},"category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=22248",{"taxonomy":182,"embeddable":26,"href":183},"post_tag","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=22248",{"taxonomy":185,"embeddable":26,"href":186},"project_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=22248",{"taxonomy":188,"embeddable":26,"href":189},"contact_email_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=22248",{"taxonomy":191,"embeddable":26,"href":192},"yst_prominent_words","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=22248",[194],{"name":195,"href":196,"templated":26},"wp","https:\u002F\u002Fapi.w.org\u002F{rel}",[198],{"id":140,"date":199,"date_gmt":200,"guid":201,"modified":203,"modified_gmt":204,"slug":205,"status":13,"type":14,"link":206,"title":207,"content":209,"excerpt":211,"author":23,"featured_media":213,"comment_status":25,"ping_status":25,"sticky":20,"template":27,"format":28,"meta":214,"categories":215,"tags":216,"project_category":230,"contact_email_category":231,"yst_prominent_words":232,"class_list":243,"better_featured_image":258,"acf":288,"yoast_meta":289,"_links":292},"2016-12-20T18:00:38","2016-12-20T16:00:38",{"rendered":202},"http:\u002F\u002Fmedicalfuturist.com\u002F?p=14660","2021-12-06T01:18:53","2021-12-06T00:18:53","what-we-learnt-in-digital-health-in-2016","https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-we-learnt-in-digital-health-in-2016",{"rendered":208},"What We Learnt in Digital Health in 2016",{"rendered":210,"protected":20},"\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"5px\"> \u003Ctbody> \u003Ctr> \u003Ctd style=\"width: 100%;\"> \u003Cp style=\"color: #555;font-size: 12px;line-height: 14px\">THIS ARTICLE HAS NOT BEEN UPDATED SINCE 2016. THE INFORMATION SHARED IN THE ARTICLE WAS ACCURATE AT THE TIME OF ITS PUBLICATION, BUT IT MAY BE OUT OF DATE NOW. \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fmagazine\">BROWSE OUR LATEST ARTICLES HERE\u003C\u002Fa>\u003C\u002Fp> \u003C\u002Ftd> \u003C\u002Ftr> \u003C\u002Ftbody> \u003C\u002Ftable> \u003Cp> \u003C\u002Fp>\n\n\n\n\u003Cp>In order to successfully move into 2017, it is crucial to draw the lessons of the past year in terms of successes, failures, remaining challenges and impenetrable obstacles in the field of digital health. Food for thought!\u003C\u002Fp>\n\n\n\n\u003C!--more-->\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>An impulsive year in science and healthcare\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>2016 was a bold, busy and impulsive year in science and healthcare. Elon Musk, CEO of Tesla, founder of SpaceX and great visionary raised the stakes in astronautics again for the greatest pleasure of the fans of space flights. \u003Ca href=\"http:\u002F\u002Fwww.bbc.com\u002Fnews\u002Fscience-environment-37486372\">He promised no less than to take humanity to Mars\u003C\u002Fa> as soon as possible (I explored the medical challenges of the project \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Four-galactic-future-depends-on-digital-health-technologies\u002F\">here\u003C\u002Fa>). In July, NASA’s \u003Ca href=\"http:\u002F\u002Fwww.nytimes.com\u002F2016\u002F07\u002F05\u002Fscience\u002Fjuno-enters-jupiters-orbit-capping-5-year-voyage.html\">Juno spacecraft entered Jupiter’s orbit\u003C\u002Fa>, a great milestone in a five-year-long journey on a $1.1 billion mission. In October, \u003Ca href=\"http:\u002F\u002Fwww.nytimes.com\u002F2016\u002F10\u002F06\u002Fscience\u002Fnobel-prize-chemistry.html\">the Nobel Prize in chemistry was awarded\u003C\u002Fa> to three brilliant scientists very simply for having developed molecules with controllable movements, acknowledging \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fgetting-smaller-and-smarter-nanotechnology-in-healthcare\u002F\">the immense potential in nanotechnology\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Cp>Uber’s driverless cars appeared on the street of Pittsburgh, and I mapped the potential \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-driverless-car-for-healthcare\u002F\">medical application of automated cars as new points-of-care\u003C\u002Fa>. The developers of Hyperloop Transportation Technologies announced that travelling in the futuristic hyperloop pods shooting through a tube above the ground \u003Ca href=\"http:\u002F\u002Fphys.org\u002Fnews\u002F2016-09-hyperloop-low-cost-futuristic.html\">will be possible in four years\u003C\u002Fa>. The \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fcrispr\u002F\">amazing genome editing tool, CRISPR\u003C\u002Fa> \u003Ca href=\"http:\u002F\u002Fwww.nature.com\u002Fnews\u002Ffirst-crispr-clinical-trial-gets-green-light-from-us-panel-1.20137\">got a green light from the US National Institutes of Health\u003C\u002Fa> for clinical trials. In March, HoloLens, Microsoft’s augmented reality (AR) viewer \u003Ca href=\"http:\u002F\u002Fwww.techradar.com\u002Freviews\u002Fwearables\u002Fmicrosoft-hololens-1281834\u002Freview\">went on sale for developers\u003C\u002Fa> eager to take risks by investing in new technologies. It is exciting news taken into account how \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Faugmented-reality-in-healthcare-will-be-revolutionary\u002F\">augmented (and for that matter, also virtual) reality might transform whole areas in medicine\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"545\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fhealthcare-progress-2016.jpg\" alt=\"Healthcare Progress - Digital Health in 2016\" class=\"wp-image-14664\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fhealthcare-progress-2016.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fhealthcare-progress-2016-768x481.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fhealthcare-progress-2016-512x321.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fhealthcare-progress-2016-399x250.jpg 399w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp>The list is certainly not exhaustive, but I believe it shows the great scientific and medical progress we experienced in 2016. Of course, I do not want to sound overoptimistic: many unsuccessful attempts, impenetrable obstacles and unsolved challenges characterized 2016. These experiences are the most important in terms of our ability for successfully moving forward. We have to draw the right lessons – and we have to learn from them.\u003C\u002Fp>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>Here are a few thoughts to consider before we dive into 2017.\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>1) Regulations are slow\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>Bureaucratic machines and mammoth-like systems are slow. They cannot keep up with the pace of innovation, especially the technological innovation of the 21\u003Csup>st\u003C\u002Fsup> century. It sounds evident, but I cannot stress its importance enough. It is the number one reason why the application of amazing medical technologies is in delay for so many areas.\u003C\u002Fp>\n\n\n\n\u003Cp>Look at the example of the artificial pancreas. It basically replicates what a healthy version of the organ does on its own; and it enables diabetes patients to live an easier life in a sustainable way. As there was no single device on the medical market, which was able to monitor blood sugar and supply insulin automatically, creative persons invented a DIY version from existing technologies. A grass-root (social media) movement called #wearenotwaiting grew out of the initiative, who campaigned for the introduction of such artificial pancreas on the market for years persistently. One of the leading figures of the movement, \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fliving-with-an-artificial-pancreas\u002F\">Dana Lewis told me how an artificial pancreas eases everyday life\u003C\u002Fa>. She has been using the device for almost two years by the time the \u003Ca href=\"https:\u002F\u002Fwww.bloomberg.com\u002Fnews\u002Farticles\u002F2016-09-28\u002Fartificial-pancreas-approved-by-fda-is-first-such-device-in-u-s\">US Food and Drug Administration finally approved it.\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"580\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fartificial-pancreas.jpg\" alt=\"Artificial Pancreas - Medical Technologies of 2017\" class=\"wp-image-14583\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fartificial-pancreas.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fartificial-pancreas-768x512.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fartificial-pancreas-512x341.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fartificial-pancreas-375x250.jpg 375w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>2) The rise and fall of Theranos\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>One drop of blood – and patients will know more about their illnesses than ever before in their whole lives. That was the promise of Theranos, founded by Stanford-graduate Elizabeth Holmes in 2003. It was the disruptive dream: to make blood-testing cheap, flexible, easily portable and above all – reliable. Everyone believed it is one of the greatest medical inventions of the century. By 2014, Theranos had raised more than $400 million in funding with an estimated value of $9 billion.\u003C\u002Fp>\n\n\n\n\u003Cp>But after one decade of blind expectations, \u003Ca href=\"http:\u002F\u002Fwww.wsj.com\u002Farticles\u002Ftheranos-has-struggled-with-blood-tests-1444881901\">The Wall Street Journal dropped the bomb\u003C\u002Fa>. In October 2015 it raised serious concerns about the viability of the project. At the beginning of 2016, I described \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhy-theranos-will-decide-the-future-of-medical-innovation\u002F\">how the fate of Theranos would have a huge impact\u003C\u002Fa> on the future of medical innovation, and that 2016 is going to be a decisive year for the company.\u003C\u002Fp>\n\n\n\n\u003Cp>As a reaction to the extensive coverage about the company, a comprehensive investigation was launched. \u003Ca href=\"http:\u002F\u002Fwww.wsj.com\u002Farticles\u002Fu-s-regulator-bans-theranos-ceo-elizabeth-holmes-from-operating-labs-for-two-years-1467956064\">In July, regulators decided\u003C\u002Fa> to revoke its license to operate a lab in California because of unsafe practices. They also banned Holmes from the blood-testing business for at least two years. Theranos announced it would close its laboratory operations and wellness centres to work on miniature medical testing machines in October 2016. That’s a major backlash to the once $9 billion worth company. \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhy-theranos-will-decide-the-future-of-medical-innovation\u002F\">There is not even proof or evidence that truly did what they claim they did.\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"445\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Ftheranos-elizabeth-holmes.jpg\" alt=\"Theranos - Digital Health in 2016\" class=\"wp-image-14666\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Ftheranos-elizabeth-holmes.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Ftheranos-elizabeth-holmes-768x393.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Ftheranos-elizabeth-holmes-512x262.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Ftheranos-elizabeth-holmes-458x234.jpg 458w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>3) Amazing new technologies are still too expensive\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>Although Microsoft’s HoloLens went on sale for developers in March, we still have to wait for its everyday use for a while – not least due to its exorbitant price. You can order the \u003Ca href=\"https:\u002F\u002Fwww.microsoftstore.com\u002Fstore\u002Fmsusa\u002Fen_US\u002Flist\u002FcategoryID.4798803400?icid=hololens_search_redirect_09222016\">Development Edition for $3000 and the Commercial Suite for $5000\u003C\u002Fa>. Oculus Rift, one of the greatest VR devices promising the magic of presence, \u003Ca href=\"https:\u002F\u002Fwww3.oculus.com\u002Fen-us\u002Frift\u002F\">costs $600-$800\u003C\u002Fa>. These prices are definitely not for mainstream users. Although Google Cardboard offers an easily accessible and cheaper solution \u003Ca href=\"https:\u002F\u002Fvr.google.com\u002Fintl\u002Fen_us\u002Fcardboard\u002Fget-cardboard\u002F\">with its price range between $10 and $20\u003C\u002Fa>, it is definitely not enough. As the saying goes, one swallow does not make a summer.\u003C\u002Fp>\n\n\n\n\u003Cp>And \u003Ca href=\"http:\u002F\u002Fwww.wired.com\u002F2016\u002F04\u002Fmagic-leap-vr\u002F\">Magic Leap\u003C\u002Fa>, the VR-company located in Florida has not even showed a prototype about its product yet. It calls mixed reality (MR), namely the mixture of AR and VR solutions, and has amazing marketing videos, but there is no proof that Magic Leap would work in practice.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"489\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fdigital-technologies-are-too-expensive.jpg\" alt=\"Digital Technologies Are Too Expensive - Digital Health in 2016\" class=\"wp-image-14667\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fdigital-technologies-are-too-expensive.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fdigital-technologies-are-too-expensive-370x208.jpg 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fdigital-technologies-are-too-expensive-768x432.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fdigital-technologies-are-too-expensive-512x288.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fdigital-technologies-are-too-expensive-444x250.jpg 444w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>4) Precision medicine has to fight for its place\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>Too many are still \u003Ca href=\"https:\u002F\u002Fwww.theatlantic.com\u002Fhealth\u002Farchive\u002F2016\u002F12\u002Fthe-peril-of-overhyping-precision-medicine\u002F510326\u002F\">skeptical about precision medicine\u003C\u002Fa>, the compilation of medical practices aiming at healing patients with the fewest possible side effects and negative impacts by applying personalized treatments. I generally believe precision medicine is the only viable future for healthcare. Although I know its limitations. Currently, it is too expensive and it is difficult to gather enough data in such a short amount of time. I also try to be cautious with innovation and to identify \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-12-most-overhyped-technologies-in-healthcare\u002F\">overhyped technologies\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Cp>Still, I think nanotechnology, genetics and surgery all hold great promise for precision medicine in many areas. Look at cancer treatment. Today, one of the most common practice is chemotherapy. In spite of the fact that it does not only destroy cancerous cells, but also healthy ones. In the future, with the help of nanotechnology, drugs might be delivered precisely to the cells to be healed. Another possibility would include medical professionals using \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002F9-exciting-medical-robot-facts\u002F\">surgical robots such as da Vinci Surgical System\u003C\u002Fa>. Such devices are capable of performing operations with previously unachievable precision. The future also holds targeted treatments. Companies such as \u003Ca href=\"https:\u002F\u002Fwww.foundationmedicine.com\u002F\">Foundation Medicine\u003C\u002Fa> are creating customized treatment plans based on the genetic makeup of the patient’s tumor. They sequence DNA from the tumor, and try to match the key mutations to drugs on the market or clinical trials already on the way. Over time, this might become the standard for assigning cancer treatment regimes.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"575\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fprecision-medicine.jpg\" alt=\"Precision Medicine - Digital Health in 2016\" class=\"wp-image-14669\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fprecision-medicine.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fprecision-medicine-768x508.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fprecision-medicine-512x338.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fprecision-medicine-378x250.jpg 378w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>5) No access to our DNA\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fshall-we-sequence-genomes-at-homes-the-future-of-genomics\u002F\">I have had four genetic tests\u003C\u002Fa> in my life so far, and I received valuable information about my health and body each time. Patients had been able to order such tests online with \u003Ca href=\"https:\u002F\u002Fwww.23andme.com\u002F\">23andme\u003C\u002Fa>, \u003Ca href=\"https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FNavigenics\">Navigenics\u003C\u002Fa> or \u003Ca href=\"https:\u002F\u002Fwww.pathway.com\u002F\">Pathway Genomics\u003C\u002Fa> since 2005, 2006 and 2007 for a while; then regulators stepped in and started to roll obstacles into their ways. \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fshall-we-sequence-genomes-at-homes-the-future-of-genomics\u002F\">Their basic idea is that anyone should be able to order a test from home\u003C\u002Fa>, learn about their risks for certain medical conditions, and what lifestyle choices they should make to avoid them.\u003C\u002Fp>\n\n\n\n\u003Cp>The US Food and Drug Administration (FDA) forced 23andMe to \u003Ca href=\"http:\u002F\u002Fwww.popsci.com\u002Farticle\u002Fscience\u002Ffda-orders-personal-genomics-company-23andme-stop-selling-dna-test\">stop marketing\u003C\u002Fa> the health reports in its spit kits in 2013. Although it approved to offer its tests directly to consumers (DTC) two years later, patients still do not have access to enough information to truly understand their results. Tests are still too expensive and 23andMe can only run tests that have been approved by the FDA. Generally speaking, DTC genetic companies still cannot provide services for patients they are truly designed for, and they are only allowed to send raw data without the analysis. In 2016, I still have no access to the underlying information in my DNA.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"756\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Faccess-to-dna-results.jpg\" alt=\"Access To DNA Results - Digital Health in 2016\" class=\"wp-image-14670\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Faccess-to-dna-results.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Faccess-to-dna-results-768x667.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Faccess-to-dna-results-512x445.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Faccess-to-dna-results-288x250.jpg 288w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>6) People are afraid of bionic\u002Fcyborg technologies\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>I feel you. The world is huge, full of imbalances and incertitude. No one knows what the future brings, which is pretty scary. It especially rings a bell concerning new technologies. Not that surprisingly, the most popular articles on TMF are the ones focusing on \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fscary-medical-technologies-we-have-to-get-used-to\u002F\">how scary technologies might be\u003C\u002Fa> or \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fdisruptive-technologies-bioterrorism\u002F\">how bioterrorism might get a boost in the future\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Cp>People have been afraid of the unknown since the dawn of times. Thus, my mission is to get you familiarized with new technologies to be able to enter the new era of healthcare with confidence and knowledge. I already listed \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhy-people-should-not-fear-digital-health\u002F\">10 reasons why people should not fear digital technologies\u003C\u002Fa>, but I’m going to continue. Talking about our dreads and fears in connection with novelties in science and health has never been more timely, so keep following me!\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"435\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fcyborg.jpg\" alt=\"Cyborg - Digital Health in 2016\" class=\"wp-image-14674\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fcyborg.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fcyborg-768x384.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fcyborg-512x256.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fcyborg-458x229.jpg 458w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>7) People acknowledge AI if they start using it\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>Do you remember the feeling when you first tried to ride a bicycle or went swimming into deep water? For me, it was a combination of fear and excitement. Later on, fear disappeared completely. It is the same with new technologies such as artificial intelligence. People will acknowledge its benefits when they start using it. \u003Ca href=\"http:\u002F\u002Fwww.ibm.com\u002Fwatson\u002F\">IBM Watson\u003C\u002Fa>, the company’s advanced artificial intelligence program \u003Ca href=\"http:\u002F\u002Fnewsroom.questdiagnostics.com\u002F2016-10-18-IBM-and-Quest-Diagnostics-Launch-Watson-Powered-Genomic-Sequencing-Service-to-Help-Physicians-Bring-Precision-Cancer-Treatments-to-Patients-Nationwide\">was recently made available widely at US Clinics\u003C\u002Fa>. The so-called Watson for Genomics helps advance precision medicine by combining cognitive computing with genomic tumor sequencing. I also presented \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-is-using-ibm-watson-in-medicine-like\u002F\">how physicians use Watson on a daily basis\u003C\u002Fa>. When physicians get a chance to see it in action, they stop being reluctant to adapting them.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"667\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fartificial-intelligence.jpg\" alt=\"Artificial Intelligence - Digital Health in 2016\" class=\"wp-image-14676\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fartificial-intelligence.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fartificial-intelligence-768x589.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fartificial-intelligence-512x393.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002Fartificial-intelligence-326x250.jpg 326w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>8) No smart algorithms analyzing wearable data\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>Around a \u003Ca href=\"http:\u002F\u002Fwww.wareable.com\u002Fwearable-tech\u002F245-million-wearable-devices-sold-2019-1606\">hundred million\u003C\u002Fa> wearable units to measure health parameters were sold in 2015. It is predicted that 245 million wearable devices will be sold in 2019. There are already tens of millions of wearable sensors and healthcare gadgets in the pockets of people worldwide. But where are the smart algorithms? Where are the artificial intelligence programs being able to analyze people’s own Big Data?\u003C\u002Fp>\n\n\n\n\u003Cp>Unfortunately, the development is in delay due to various reasons. The result? I still need to analyze my own data and draw conclusions about lifestyle choices myself.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"373\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F11\u002Fwearables.png\" alt=\"Wearables - Live Healthier\" class=\"wp-image-14471\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F11\u002Fwearables.png 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F11\u002Fwearables-768x329.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F11\u002Fwearables-512x220.png 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F11\u002Fwearables-458x196.png 458w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>9) No food scanners\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>Currently, we have absolutely no idea, \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-future-of-food-the-food-of-the-future\u002F\">what we are eating – not to speak about what we should\u003C\u002Fa>. \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Ffood-scanners\u002F\">Food scanners promised they will be able to tell\u003C\u002Fa> how many grams of sugar a piece of fruit contains, or what the alcohol percentage of a drink is. Canadian \u003Ca href=\"http:\u002F\u002Ftellspec.com\u002F\">TellSpec\u003C\u002Fa> had a successful crowdfunding campaign in 2013 and raised more than $380,000. It announced its aim is to develop a hand–held food scanner that can inform users as about specific ingredients and macronutrients. They sent out the first devices to beta testers in mid-2015. However, the market launch is in serious delay jeopardizing the company’s reputation.\u003C\u002Fp>\n\n\n\n\u003Cp>The Israeli company \u003Ca href=\"https:\u002F\u002Fwww.consumerphysics.com\u002Fmyscio\u002F\">SCiO\u003C\u002Fa>  raised over $2.7 million on Kickstarter in 2014. It uses a technology similar to TellSpec’s but is designed to identify the molecular content of foods, medicines, and even plants. The company promises that in milliseconds the ingredients and molecular make–up of the foodstuff will appear on the user’s smartphone. The device was scheduled for shipment in 2015, but disappointed backers, as it still hasn’t shipped. On top of the delays, experts in applied science criticized both SCiO and TellSpec for overstating what their inventions can do.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"489\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F10\u002Ftellspec.jpg\" alt=\"TellSpec - Future of Food\" class=\"wp-image-14347\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F10\u002Ftellspec.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F10\u002Ftellspec-370x208.jpg 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F10\u002Ftellspec-768x432.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F10\u002Ftellspec-512x288.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F10\u002Ftellspec-444x250.jpg 444w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>10) The relationship between Boston Dynamics and Google is over?\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>\u003Ca href=\"http:\u002F\u002Fwww.bostondynamics.com\u002F\">Boston Dynamics\u003C\u002Fa>, the engineering and robotics design company meant the future when it came to robotics in 1992. It was so promising that \u003Ca href=\"http:\u002F\u002Fuk.businessinsider.com\u002Freport-google-trying-to-sell-boston-dynamics-2016-3?r=US&IR=T\">Google X bought it for hundreds of millions in 2013\u003C\u002Fa>. They produced \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fboston-dynamics-showcases-their-robotic-animal-park\u002F\">mind-blowing videos\u003C\u002Fa> and even more inspiring robotics developments. However, \u003Ca href=\"https:\u002F\u002Fwww.bloomberg.com\u002Fnews\u002Farticles\u002F2016-03-17\u002Fgoogle-is-said-to-put-boston-dynamics-robotics-unit-up-for-sale\">in March, Google announced that it is ready to sell it\u003C\u002Fa> since BD was rather reluctant to work with Google’s other robot engineers, and the unit reportedly failed to come up with marketable products in the near term. Toyota and Amazon was aired as potential buyers. In May, Tech Times reported “the ink was almost dry” on the purchase of the company to Toyota. But since then, no news about the business being sealed.\u003C\u002Fp>\n\n\n\n\u003Cp>It seems that life still goes on at BD: throughout the year, the company introduced an \u003Ca href=\"https:\u002F\u002Fwww.engadget.com\u002F2016\u002F12\u002F02\u002Fthe-atlas-robot-is-getting-better-at-chasing-you-down\u002F\">improved version of their Atlas robot\u003C\u002Fa> and taught its robot dog, \u003Ca href=\"http:\u002F\u002Fqz.com\u002F714949\u002Falphabet-has-a-new-robot-that-can-do-chores-and-shake-its-booty-in-your-living-room\u002F\">SpotMini how to hand over coke to a human\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\">\u003Cdiv class=\"wp-block-embed__wrapper\">\n\u003Ciframe loading=\"lazy\" title=\"Introducing Spot (previously SpotMini)\" width=\"640\" height=\"360\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002Ftf7IEVTDjng?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen>\u003C\u002Fiframe>\n\u003C\u002Fdiv>\u003C\u002Ffigure>\n\n\n\n\u003Ch1 class=\"wp-block-heading\">\u003Cstrong>11) 3D bioprinting has a future\u003C\u002Fstrong>\u003C\u002Fh1>\n\n\n\n\u003Cp>\u003Ca href=\"http:\u002F\u002Fwww.organovo.com\u002F\">Organovo\u003C\u002Fa> is going to prove to be a true success story! It has been in the spotlight because of 3D printing biomaterials for years. They announced successfully bioprinted liver tissues in 2014 and they seemed to be 4-6 years away from printing liver parts for transplantation. But these bioprinted livers could also be used in the pharmaceutical industry to replace animal models for analyzing the toxicity of new drugs.\u003C\u002Fp>\n\n\n\n\u003Cp>A few months ago, Organovo launched its second commercial product, bioprinted human kidney tissue. In December, \u003Ca href=\"http:\u002F\u002Fwww.fool.com\u002Finvesting\u002F2016\u002F12\u002F01\u002F3-ways-organovo-holdings-inc-plans-to-grow-exponen.aspx\">Keith Murphy, CEO announced\u003C\u002Fa> that the company expects triple-digit percentages in growth for years to come by driving the adoption of bioprinting, by expanding their products and offerings. I am hopeful to see Organovo’s growth in the next year!\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"870\" height=\"404\" src=\"https:\u002F\u002F1712507217.rsc.cdn77.org\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002F3d-bioprinting-organovo.jpg\" alt=\"3D bioprinting Organovo - Digital Health in 2016\" class=\"wp-image-14677\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002F3d-bioprinting-organovo.jpg 870w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002F3d-bioprinting-organovo-768x357.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002F3d-bioprinting-organovo-512x238.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002F3d-bioprinting-organovo-458x212.jpg 458w\" sizes=\"auto, (max-width: 870px) 100vw, 870px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fthe-most-exciting-medical-technologies-of-2017\u002F\">2017 will be an even more exciting year in digital health\u003C\u002Fa> and we have a lot to do not to make the same mistakes, to overcome the obstacles and to rise up to the challenges. Let’s learn from things that took place in 2016 and check the predictions for 2017.\u003C\u002Fp>\n\n\n\u003Cp>[subscribe image=”false” type=”article-horizontal”]Subscribe to\u003C\u002Fp>\n\u003Ch2 style=\"text-align: justify;\">\u003Cb>The Medical Futurist℠ Newsletter\u003C\u002Fb>\u003C\u002Fh2>\n\u003Cul style=\"text-align: justify;\">\n\u003Cli>News shaping the future of healthcare\u003C\u002Fli>\n\u003Cli>Advice on taking charge of your health\u003C\u002Fli>\n\u003Cli>Reviews of the latest health technology\u003C\u002Fli>\n\u003C\u002Ful>\n\u003Cp style=\"text-align: justify;\">[\u002Fsubscribe]\u003C\u002Fp>\n",{"rendered":212,"protected":20},"\u003Cp>THIS ARTICLE HAS NOT BEEN UPDATED SINCE 2016. THE INFORMATION SHARED IN THE ARTICLE WAS ACCURATE AT THE TIME OF ITS PUBLICATION, BUT IT MAY […]\u003C\u002Fp>\n",14682,{"_acf_changed":20,"footnotes":27},[32],[42,217,218,219,220,221,222,223,224,225,226,36,227,38,35,228,229],607,377,608,445,453,517,144,524,196,530,533,266,604,[],[],[233,234,235,236,237,238,239,240,241,242],2935,1571,1617,1619,1621,1715,1721,1723,1831,2017,[244,14,73,74,75,76,77,79,88,245,246,247,248,249,250,251,252,253,254,82,255,84,81,256,257],"post-14660","tag-boston-dynamics","tag-robotics-2","tag-precision-medicine","tag-virtual-reality","tag-wearables-2","tag-gc1","tag-artificial-intelligence","tag-trackers","tag-data-2","tag-big-data","tag-artificial-pancreas","tag-google-2","tag-food-scanner",{"id":213,"alt_text":27,"caption":27,"description":27,"media_type":96,"media_details":259,"post":140,"source_url":287},{"width":260,"height":261,"file":262,"sizes":263,"image_meta":285},870,405,"2016\u002F12\u002FDigital-Health-in-2016-1.jpg",{"medium":264,"large":268,"thumbnail":272,"medium_large":275,"large_old_512x238":276,"medium_old_458x213":280},{"file":265,"width":104,"height":105,"mime-type":266,"source_url":267},"Digital-Health-in-2016-1-370x208.jpg","image\u002Fjpeg","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002FDigital-Health-in-2016-1-370x208.jpg",{"file":269,"width":110,"height":270,"mime-type":266,"source_url":271},"Digital-Health-in-2016-1-768x358.jpg",358,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002FDigital-Health-in-2016-1-768x358.jpg",{"file":273,"width":115,"height":115,"mime-type":266,"source_url":274},"Digital-Health-in-2016-1-150x150.jpg","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002FDigital-Health-in-2016-1-150x150.jpg",{"file":269,"width":110,"height":270,"mime-type":266,"source_url":271},{"file":277,"width":125,"height":278,"mime-type":266,"source_url":279},"Digital-Health-in-2016-1-512x238.jpg",238,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002FDigital-Health-in-2016-1-512x238.jpg",{"file":281,"width":282,"height":283,"mime-type":266,"source_url":284},"Digital-Health-in-2016-1-458x213.jpg",458,213,"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002FDigital-Health-in-2016-1-458x213.jpg",{"aperture":129,"credit":27,"camera":27,"caption":27,"created_timestamp":129,"copyright":27,"focal_length":129,"iso":129,"shutter_speed":129,"title":27,"orientation":129,"keywords":286},[],"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2016\u002F12\u002FDigital-Health-in-2016-1.jpg",{"cta_type":27,"cta_color":27,"subtitle":27,"related_books":20,"related_posts_footer":20,"related_posts":20},{"yoast_wpseo_title":290,"yoast_wpseo_metadesc":291,"yoast_wpseo_canonical":206},"What We Learnt in Digital Health in 2016 - The Medical Futurist","In order to successfully move into 2017, it is crucial to draw the lessons of the past in healthcare Here are my thoughts about digital health in 2016.",{"self":293,"collection":298,"about":300,"author":302,"replies":304,"version-history":307,"predecessor-version":311,"wp:featuredmedia":315,"wp:attachment":318,"wp:term":321,"curies":332},[294],{"href":295,"targetHints":296},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F14660",{"allow":297},[150],[299],{"href":153},[301],{"href":156},[303],{"embeddable":26,"href":159},[305],{"embeddable":26,"href":306},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=14660",[308],{"count":309,"href":310},8,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F14660\u002Frevisions",[312],{"id":313,"href":314},37381,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F14660\u002Frevisions\u002F37381",[316],{"embeddable":26,"href":317},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F14682",[319],{"href":320},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=14660",[322,324,326,328,330],{"taxonomy":179,"embeddable":26,"href":323},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=14660",{"taxonomy":182,"embeddable":26,"href":325},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=14660",{"taxonomy":185,"embeddable":26,"href":327},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=14660",{"taxonomy":188,"embeddable":26,"href":329},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=14660",{"taxonomy":191,"embeddable":26,"href":331},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=14660",[333],{"name":195,"href":196,"templated":26},[],1789987469512]